Targeting p53 Cancer Therapies - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Targeting p53 Cancer Therapies Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Targeting p53 Cancer Therapies Market Restraints
Table 3. Targeting p53 Cancer Therapies Market Trends
Table 4. Targeting p53 Cancer Therapies Industry Policy
Table 5. Global Targeting p53 Cancer Therapies Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Targeting p53 Cancer Therapies Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Targeting p53 Cancer Therapies Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Targeting p53 Cancer Therapies Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Targeting p53 Cancer Therapies Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Targeting p53 Cancer Therapies Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Targeting p53 Cancer Therapies Mergers & Acquisitions, Expansion Plans
Table 12. Global Targeting p53 Cancer Therapies Manufacturers Product Type
Table 13. Head Office and Targeting p53 Cancer Therapies Production Site of Key Manufacturer
Table 14. Targeting p53 Cancer Therapies Capacity of Major Manufacturers and Future Plan
Table 15. China Targeting p53 Cancer Therapies Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Targeting p53 Cancer Therapies Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Targeting p53 Cancer Therapies Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Targeting p53 Cancer Therapies Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Targeting p53 Cancer Therapies Production by Region, 2018-2023, (K Units)
Table 20. Global Targeting p53 Cancer Therapies Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Targeting p53 Cancer Therapies Upstream (Raw Materials)
Table 22. Global Targeting p53 Cancer Therapies Typical Customers
Table 23. Targeting p53 Cancer Therapies Typical Distributors
Table 24. By Type, Global Targeting p53 Cancer Therapies Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Targeting p53 Cancer Therapies Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Targeting p53 Cancer Therapies Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Targeting p53 Cancer Therapies Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Targeting p53 Cancer Therapies Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Targeting p53 Cancer Therapies Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Targeting p53 Cancer Therapies Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Targeting p53 Cancer Therapies Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Targeting p53 Cancer Therapies Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Targeting p53 Cancer Therapies Sales Quantity Market Share, 2018-2029
Table 34. Sibiono GeneTech Company Information, Head Office, Market Area, and Industry Position
Table 35. Sibiono GeneTech Targeting p53 Cancer Therapies Models, Specifications, and Application
Table 36. Sibiono GeneTech Targeting p53 Cancer Therapies Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Sibiono GeneTech Company Profile and Main Business
Table 38. Sibiono GeneTech Recent Developments
Table 39. Kartos Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 40. Kartos Therapeutics Targeting p53 Cancer Therapies Models, Specifications, and Application
Table 41. Kartos Therapeutics Targeting p53 Cancer Therapies Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Kartos Therapeutics Company Profile and Main Business
Table 43. Kartos Therapeutics Recent Developments
Table 44. SynerGene Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 45. SynerGene Therapeutics Targeting p53 Cancer Therapies Models, Specifications, and Application
Table 46. SynerGene Therapeutics Targeting p53 Cancer Therapies Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. SynerGene Therapeutics Company Profile and Main Business
Table 48. SynerGene Therapeutics Recent Developments
Table 49. MultiVir Company Information, Head Office, Market Area, and Industry Position
Table 50. MultiVir Targeting p53 Cancer Therapies Models, Specifications, and Application
Table 51. MultiVir Targeting p53 Cancer Therapies Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. MultiVir Company Profile and Main Business
Table 53. MultiVir Recent Developments
Table 54. Rain Oncology Company Information, Head Office, Market Area, and Industry Position
Table 55. Rain Oncology Targeting p53 Cancer Therapies Models, Specifications, and Application
Table 56. Rain Oncology Targeting p53 Cancer Therapies Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Rain Oncology Company Profile and Main Business
Table 58. Rain Oncology Recent Developments
Table 59. Alieron Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 60. Alieron Therapeutics Targeting p53 Cancer Therapies Models, Specifications, and Application
Table 61. Alieron Therapeutics Targeting p53 Cancer Therapies Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Alieron Therapeutics Company Profile and Main Business
Table 63. Alieron Therapeutics Recent Developments
Table 64. Aprea Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 65. Aprea Therapeutics Targeting p53 Cancer Therapies Models, Specifications, and Application
Table 66. Aprea Therapeutics Targeting p53 Cancer Therapies Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Aprea Therapeutics Company Profile and Main Business
Table 68. Aprea Therapeutics Recent Developments
Table 69. Ascentage Pharma Company Information, Head Office, Market Area, and Industry Position
Table 70. Ascentage Pharma Targeting p53 Cancer Therapies Models, Specifications, and Application
Table 71. Ascentage Pharma Targeting p53 Cancer Therapies Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Ascentage Pharma Company Profile and Main Business
Table 73. Ascentage Pharma Recent Developments
Table 74. Jc (Wuxi) Company Company Information, Head Office, Market Area, and Industry Position
Table 75. Jc (Wuxi) Company Targeting p53 Cancer Therapies Models, Specifications, and Application
Table 76. Jc (Wuxi) Company Targeting p53 Cancer Therapies Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Jc (Wuxi) Company Company Profile and Main Business
Table 78. Jc (Wuxi) Company Recent Developments
List of Figures
Figure 1. Targeting p53 Cancer Therapies Picture
Figure 2. Global Targeting p53 Cancer Therapies Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Targeting p53 Cancer Therapies Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Targeting p53 Cancer Therapies Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Targeting p53 Cancer Therapies Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Targeting p53 Cancer Therapies Sales Quantity (K Units) & (2018-2029)
Figure 7. China Targeting p53 Cancer Therapies Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Targeting p53 Cancer Therapies Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Targeting p53 Cancer Therapies Market Share of Global, 2018-2029
Figure 10. Global Targeting p53 Cancer Therapies Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Targeting p53 Cancer Therapies Key Participants, Market Share, 2022
Figure 12. Global Targeting p53 Cancer Therapies Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Targeting p53 Cancer Therapies Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Targeting p53 Cancer Therapies Production Market Share & Forecast by Region, 2018-2029
Figure 15. Targeting p53 Cancer Therapies Industry Chain
Figure 16. Targeting p53 Cancer Therapies Procurement Model
Figure 17. Targeting p53 Cancer Therapies Sales Model
Figure 18. Targeting p53 Cancer Therapies Sales Channels, Direct Sales, and Distribution
Figure 19. Small Molecule Drugs
Figure 20. Immunotherapy
Figure 21. Gene Therapy
Figure 22. Others
Figure 23. By Type, Global Targeting p53 Cancer Therapies Consumption Value, 2018-2029, US$ Million
Figure 24. By Type, Global Targeting p53 Cancer Therapies Consumption Value Market Share, 2018-2029
Figure 25. By Type, Global Targeting p53 Cancer Therapies Sales Quantity, 2018-2029, (K Units)
Figure 26. By Type, Global Targeting p53 Cancer Therapies Sales Quantity Market Share, 2018-2029
Figure 27. By Type, Global Targeting p53 Cancer Therapies Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 28. Hospital
Figure 29. Clinic
Figure 30. Others
Figure 31. By Application, Global Targeting p53 Cancer Therapies Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Targeting p53 Cancer Therapies Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Targeting p53 Cancer Therapies Sales Quantity, 2018-2029, (K Units)
Figure 34. By Application, Global Targeting p53 Cancer Therapies Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Targeting p53 Cancer Therapies Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global Targeting p53 Cancer Therapies Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Targeting p53 Cancer Therapies Sales Quantity Market Share, 2018-2029
Figure 38. North America Targeting p53 Cancer Therapies Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Targeting p53 Cancer Therapies Consumption Value Market Share, 2022
Figure 40. Europe Targeting p53 Cancer Therapies Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Targeting p53 Cancer Therapies Consumption Value Market Share, 2022
Figure 42. Asia Pacific Targeting p53 Cancer Therapies Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Targeting p53 Cancer Therapies Consumption Value Market Share, 2022
Figure 44. South America Targeting p53 Cancer Therapies Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Targeting p53 Cancer Therapies Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Targeting p53 Cancer Therapies Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Targeting p53 Cancer Therapies Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, U.S. Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Targeting p53 Cancer Therapies Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, Europe Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Targeting p53 Cancer Therapies Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, China Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Targeting p53 Cancer Therapies Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, Japan Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Targeting p53 Cancer Therapies Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, South Korea Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Targeting p53 Cancer Therapies Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, Southeast Asia Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Targeting p53 Cancer Therapies Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, India Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Targeting p53 Cancer Therapies Sales Quantity, 2018-2029, (K Units)
Figure 69. By Type, Middle East & Africa Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Targeting p53 Cancer Therapies Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets